WebIn the US, Paclitaxel (paclitaxel systemic) is a member of the drug class mitotic inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Kaposi's Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer and Wilms' Tumor. US matches: Paclitaxel Paclitaxel protein-bound Paclitaxel Novaplus
Paclitaxel AqVida 6 mg/ml Injection AqVida bangladesh ...
WebApr 18, 2024 · AqVida is a German pharmaceutical manufacturer of injectable finished dosage formulation (FDF) medications. Its mission is fully dedicated to, and specialized in, the development, registration, manufacturing and distribution of injectable FDF mainly for the oncology sector. WebMar 9, 2016 · After having developed and launched several oncology parenteral forms such as e.g. Paclitaxel, Docetaxel and Oxaliplatin, AqVida and its partner company, Benavis, have started development work on the ‘tinib’ series of molecular targeted anti-cancer molecules. AqVida is also developing other molecular targeted anti-cancer molecules, … sumo fiber reviews
AqVida - Development, Registration and Supply of Generic …
Webfull prescribing information: contents* warning: toxic deaths, hepatotoxicity, neutropenia, hypersensitivity reactions, and fluid retention . 1 indications and usage WebJun 15, 2024 · OncBioMune Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, today announces an exclusive... WebPaclitaxel should not be readministered until the neutrophil count is 1.5x109/l ( .0x109/l for KS patients) and the platelet count is ≥100x109/l ( 75x10 9/l for KS patients). Patients who experience severe neutropenia (neutrophil count 0.5x10 /l for 7 days) or severe peripheral neuropathy should receive a dose reduction of 20% for subsequent ... sum of ifs in excel